2-chloroadenine
Suppliers
Names
[ CAS No. ]:
1839-18-5
[ Name ]:
2-chloroadenine
[Synonym ]:
CHLOROADENINE
2-chlor-9h-purin-6-amin
7H-Purin-6-amine, 2-chloro-
6-amino-2-chloro-9H-purine
2-chloro-7h-purin-6-amine
6-amino-2-chloropurine
6-Amino-2-chloro-7H-purine
MFCD00127773
2-Chloro-1H-purin-6-amine
2-Chloroadenine
2-CHLORO-6-AMINOPURINE
9H-purin-6-amine, 2-chloro-
2-chloropurin-6-amine
2-Chlorophenthiazine
2-chloro-9H-purin-6-amine
Purine, 6-amino-2-chloro-
Chemical & Physical Properties
[ Density]:
1.8±0.1 g/cm3
[ Boiling Point ]:
485.5±27.0 °C at 760 mmHg
[ Melting Point ]:
>300°C(dec)
[ Molecular Formula ]:
C5H4ClN5
[ Molecular Weight ]:
169.57
[ Flash Point ]:
247.4±23.7 °C
[ Exact Mass ]:
169.015518
[ PSA ]:
80.48000
[ LogP ]:
0.35
[ Vapour Pressure ]:
0.0±1.2 mmHg at 25°C
[ Index of Refraction ]:
1.827
[ Storage condition ]:
-20°C Freezer
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Precautionary Statements ]:
P301 + P312 + P330
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
22
[ RIDADR ]:
NONH for all modes of transport
[ HS Code ]:
2933990090
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933990090
[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
Cancer Lett. 210(2) , 171-7, (2004)
The nucleoside analog 2-chlorodeoxyadenosine (Cladribine, CdA) is used in the treatment of patients with several hematological malignancies. After administration of CdA, the major catabolite measured ...
Prikl. Biokhim. Mikrobiol. 44(2) , 181-6, (2008)
Cladribine (2-chloro-2'-deoxyadenosine) was synthesized using intact cells of the recombinant Escherichia coli strain producing Geobacillus stearothermophilus B-2194 thermostable purine-nucleoside pho...
J. Mol. Cell. Cardiol. 38(2) , 245-56, (2005)
Aging is associated with reduced tolerance to ischemic insult, and genesis of this intolerant phenotype is poorly understood. We characterized effects of aging and gender on cardiovascular function an...